With advancing therapeutic options, achieving a state of remission has become the treatment goal in rheumatoid arthritis. Agreeing on what constitutes remission and what measures should be used to assess disease activity has remained a challenge. Multiple remission criteria have been devised and modified, all with different strengths and limitations. A consensus definition of remission will nee...

Introduction Juvenile idiopathic arthritis (JIA) is the most common rheumatologic disorder of childhood. It is a group of diseases characterized by chronic synovitis, associated with many extra-articular manifestations including pulmonary involvement, usually in the systemic type. Alterations of pulmonary function in JIA may be a complication of the underlying disease or related to treatment wi...

Etanercept is a tumor necrosis factor alpha (TNF-a) antagonist with anti-inflammatory effects. It is used in the treatment of dermatologic and rheumatologic diseases such as rheumatoid arthritis, polyarticular juvenile rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. However, etanercept has various cutaneous and systemic side effects. Herein, we report a case of generalized...

Material and Methods Urine.-This was collected from eight female patients with severe and active rheumatoid arthritis (meeting ARA criteria), one of whom had juvenile rheumatoid arthritis. The erythrocyte sedimentation rate ranged from 30 to 90 mm. in the first hour (Westergren). The WaalerRose test was positive in five and negative in three cases. Urine was collected for control purposes from ...

A 4-year-old girl with seronegative systemic juvenile rheumatoid arthritis developed acute cardiac tamponade. Pericardiocentesis and systemic corticosteroids resulted in complete recovery of the pericardial involvement. This was followed by complete remission of rheumatoid disease.

Introduction All chronic childhood arthritides of unknown aetiology are termed as Juvenile Idiopathic Arthritis ( JIA). The disease may occur as early as 3–6 years of age, but it occasionally manifests before one year of age. JIA is the most common chronic rheumatic disease in childhood with an incidence of 10-19/100.000 children under the age of 16 years, and it is a major cause of physically ...